Listing code
114.07
Children (Part B)
Body system
114.00
Immune system disorders (children)
Subsections
2
Lettered criteria paths
Step in evaluation
3 of 5
Listing match approves the claim
SSA listing text and criteria
Immune deficiency disorders, excluding HIV infection. As described in 114.00E . With:
Subsection A
One or more of the following infections. The infection(s) must either be resistant to treatment or require hospitalization or intravenous treatment three or more times in a 12-month period. 1. Sepsis; or 2. Meningitis; or 3. Pneumonia; or 4. Septic arthritis; or 5. Endocarditis; or 6. Sinusitis documented by appropriate medically acceptable imaging. OR
- Sepsis; or
- Meningitis; or
- Pneumonia; or
- Septic arthritis; or
- Endocarditis; or
- Sinusitis documented by appropriate medically acceptable imaging. OR
Subsection B
Stem cell transplantation as described under 114.00E3 . Consider under a disability until at least 12 months from the date of transplantation. Thereafter, evaluate any residual impairment(s) under the criteria for the affected body system. Back to Top
Source: SSA Blue Book listing 114.07. Last synced 2026-05-04.
Where claims under 114.07 usually fail
One common failure is listing infections that are not on the required list (the criteria name sepsis, meningitis, pneumonia, septic arthritis, endocarditis, and sinusitis with imaging). Another is missing the time-and-severity structure in Subsection A, because the infection(s) must either be resistant to treatment or require hospitalization or intravenous treatment three or more times in a 12-month period. A third failure is treating "sinusitis" as enough without the required confirmation by appropriate medically acceptable imaging. A fourth is assuming the transplant section ends immediately after the procedure; Subsection B requires evaluating under disability until at least 12 months from the transplant date, and then evaluating any residual impairments.
Medical evidence that strengthens this claim
The strongest records for Subsection A are medical documents showing the specific infections named in the criteria (sepsis, meningitis, pneumonia, septic arthritis, endocarditis, or sinusitis) plus evidence that the infection(s) were resistant to treatment or required hospitalization or intravenous treatment three or more times within a 12-month period. For sinusitis, the documentation needs to include confirmation by appropriate medically acceptable imaging. For Subsection B, the key evidence is the stem cell transplantation date and the fact that the transplant was for the immune deficiency described under the applicable immune-system framework (as referenced by 114.00E3), because SSA uses the transplant date to set the at-least-12-month evaluation window.
What happens if your records do not meet this listing
Most denials for this listing happen when the required infection list or the timing requirement (three or more hospitalizations or IV treatments in 12 months, or treatment resistance) is not met, or the sinusitis imaging requirement is missing. If the criteria for Subsection A or the transplant timing in Subsection B are not met, SSA then moves to the remaining disability evaluation steps. If the case reaches the later functional assessment stage (residual functional capacity), the focus shifts to what the child can still do despite the immune deficiency and its treatment effects, rather than whether the infection pattern exactly matches this specific listing.
Work activity and the SGA gate for this condition
For an SSDI claim, work activity rules still apply at the start of the claim process, but the listing criteria here are about specific severe infections or stem cell transplantation in childhood. Under this listing, Subsection A is centered on sepsis, meningitis, pneumonia, septic arthritis, endocarditis, or imaging-confirmed sinusitis that leads to treatment resistance or requires hospitalization or intravenous treatment three or more times in a 12-month period. Under Subsection B, disability evaluation under this listing is considered until at least 12 months from the stem cell transplantation date, and afterward any residual impairments are evaluated under the criteria for the affected body system.
Listing 114.07 FAQ
Questions that come up repeatedly for immune deficiency disorders, excluding hiv infection disability claims.